Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 2022

View Archived Issues

IFI27L2A and IFITM3 increase their expression after stroke

US Department of Health & Human Services patents compounds for SARS-CoV-2 infection

eNAMP-neutralizing MAb reduces ARDS severity in rat and porcine models

CK-BB predicts never awakening in patients treated with hypothermia after cardiac arrest

Virpax reports preclinical findings on Envelta for acute and chronic pain

Researchers unveil therapeutic targets in ischemic stroke

Targeting TRPM2 using tat-M2NX improves functional outcome following MCAO

No pain, health gain with biochemical mimicry of caloric restriction?

Alkem signs license agreement with Harvard for technology to treat vascular disease

Regulating ANXA1 activity is an approach for treating sickle cell disease-associated stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...